National PR campaign to launch AI-enabled heart diagnostics
In Scottsdale, Arizona, a significant partnership has been announced between PR and marketing agency, Amendola Communications, and a healthcare tech firm specializing in advanced remote diagnostic and monitoring solutions for hospitals. The deal is set to see the launch of a national PR campaign for the tech firm’s AI-enabled early diagnosis of heart failure. The idea being, to revolutionize patient care standards nationwide by allowing for quick diagnosis and treatment.
The tech firm’s dedication to minimizing the impact of devastating illnesses through early diagnosis matches up perfectly with Amendola Communications’ mission – to push health technologies into the public spotlight. The date for the campaign roll-out remains a mystery, however expectations are high, showing the significance of this partnership.
Upon announcing this joint venture, the CEO of Amendola Communications expressed eagerness for bringing about transformative change to healthcare. The idea is that through utilizing cutting-edge tech, no patient will be left behind in the healthcare revolution.
For the tech company, their main partnership goal is to promote their AI-powered remote monitoring technology. They maintain strong confidence in Amendola Communications, due to their outstanding industry reputation and proven adeptness at explaining complex technology to a large audience.
Heart failure presently impacts over six million U.S. citizens, with approximately a million new cases each year.
Promoting AI-enhanced heart failure detection
The majority of these cases are amongst adults over 55, resulting in a high number of hospital admissions. Usually, though, patients aren’t diagnosed until after hospitalization – making prognosis and treatment more challenging.
In order to aid this health crisis, the tech firm has developed an AI-powered, 2-channel wireless ECG device. The device provides, with an impressive 96% accuracy rate, real-time data allowing for rapid detection and prevention of potentially fatal heart conditions.
Jodi Amendola, the CEO of Amendola Communications, is notably thrilled about the partnership. She strongly believes in the influential role this collaboration can play in reducing the impact of heart failure. She also champions the need for increased public awareness around heart failure – stating that it is a community concern as much as a medical one.
Amendola Communications, highly regarded for their PR and Marketing skills within the healthcare domain, anticipate a significant step forward in the fields of heart health and personalized medicine. All media-related inquiries should be directed to their point of contact, Marcia G. Rhodes.
